Detalhe da pesquisa
1.
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Oncologist
; 28(12): 1072-1078, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285524